Dynamics of cytomegalovirus-specific T-cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study.

Samantha E JacobsUroosa IbrahimAkasha Barreto VegaJonathan LagdameoJacquelyn CallahanUsha GovindarajuluMelissa GitmanJohn E LevineMeenakshi RanaAlla Keyzner

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2024)

There was significant variability in time to CMV-CMI recovery post-HCT, with slower recovery after haploidentical and mismatched HCT. CD4+ CMV-CMI may protect against CS-CMVi, but immunity may be lost with GVHD diagnosis and treatment.

Keyphrases

flow cytometry
bone marrow
stem cell transplantation
cell cycle arrest
single cell
high dose
cell therapy
mesenchymal stem cells
epstein barr virus
allogeneic hematopoietic stem cell transplantation
stem cells
hematopoietic stem cell
low dose